People news: Pfizer, Epocrates, GCI and Spectrum

Share this article:
Mobile reference firm Epocrates appointed former Pfizer executive Peter Brandt to its board of directors. Brandt will join the board's audit and compensation committees and is expected to provide strategic direction on Epocrates' interactive services for the healthcare industry. Brandt held leadership positions at Pfizer for two decades, ultimately serving as president of its US pharma business. He also led Pfizer Health Solutions, a clinical technology unit.

GCI Health named Elisia Canna director of consumer health, reporting to CEO Wendy Lund. Canna joins GCI from Porter Novelli, where she was EVP deputy general manager of the New York health practice and led the launches of Nicorette, NicoDerm CQ and Commit Lozenge, along with the Great American Smokeout.

Spectrum rehired Lissette Capati as VP. Capati returns to the agency from Zeno Group, where she led corporate and scientific communications and social media campaigns for clients in the company's health care practice.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media